Yan‐Lai Tang

1.2k total citations
50 papers, 722 citations indexed

About

Yan‐Lai Tang is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Yan‐Lai Tang has authored 50 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 10 papers in Hematology. Recurrent topics in Yan‐Lai Tang's work include Retinoids in leukemia and cellular processes (10 papers), Acute Myeloid Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Yan‐Lai Tang is often cited by papers focused on Retinoids in leukemia and cellular processes (10 papers), Acute Myeloid Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Yan‐Lai Tang collaborates with scholars based in China, Hong Kong and United States. Yan‐Lai Tang's co-authors include Xue‐Qun Luo, Libin Huang, Wuguo Deng, Xi Sun, Zhiyong Ke, Lifu Wang, Zhenyu Wu, Dingbo Shi, Jingshu Wang and Ge Qin and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Yan‐Lai Tang

46 papers receiving 718 citations

Peers

Yan‐Lai Tang
Yan‐Lai Tang
Citations per year, relative to Yan‐Lai Tang Yan‐Lai Tang (= 1×) peers José Manuel García-Castellano

Countries citing papers authored by Yan‐Lai Tang

Since Specialization
Citations

This map shows the geographic impact of Yan‐Lai Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Lai Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Lai Tang more than expected).

Fields of papers citing papers by Yan‐Lai Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Lai Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Lai Tang. The network helps show where Yan‐Lai Tang may publish in the future.

Co-authorship network of co-authors of Yan‐Lai Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Lai Tang. A scholar is included among the top collaborators of Yan‐Lai Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Lai Tang. Yan‐Lai Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Zichen, Xi Sun, Yingli Liu, et al.. (2025). Arsenic trioxide-induced pyroptosis promotes the release of HMGB1 to activate natural killer cells related immunogenic cell death in leukemia. Chinese Chemical Letters. 111585–111585. 1 indexed citations
2.
Ma, Zilong, et al.. (2024). Advancing polarity-transcendent design: Development of a photoelectrochemical sensor with extended detection range. Biosensors and Bioelectronics. 266. 116736–116736. 7 indexed citations
3.
Su, Shu, Hongbin Qiu, Lianhong Cai, et al.. (2024). Assessing changes in brain structure in new-onset children with acute lymphoblastic leukemia. Pediatric Research. 97(7). 2398–2404. 1 indexed citations
4.
Liao, Ning, Xinyu Li, Lihua Yang, et al.. (2024). Prognosis of pediatric BCPALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG‐2016 study. European Journal Of Haematology. 113(3). 357–370.
5.
Wang, Lina, Li Yu, Cong Liang, et al.. (2024). The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia. Technology in Cancer Research & Treatment. 23. 2223964968–2223964968. 2 indexed citations
6.
Wang, Wenqing, et al.. (2024). Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study. BMC Pediatrics. 24(1). 540–540. 2 indexed citations
7.
8.
Chen, Jun-zhu, Lina Wang, Xue‐Qun Luo, & Yan‐Lai Tang. (2023). The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening. Frontiers in Oncology. 13. 1178686–1178686. 1 indexed citations
9.
Qin, Le, Jiang Lv, Di Wu, et al.. (2023). The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer. International Immunopharmacology. 121. 110402–110402. 7 indexed citations
10.
Li, Jianan, Yu Li, Lina Wang, et al.. (2023). Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children. Frontiers in Immunology. 14. 1280759–1280759.
11.
Su, Shu, Libin Huang, Qin Zhou, et al.. (2023). Glymphatic system dysfunction in pediatric acute lymphoblastic leukemia without clinically diagnosed central nervous system infiltration: a novel DTI-ALPS method. European Radiology. 33(5). 3726–3734. 14 indexed citations
12.
Kong, Qian, Xinyu Li, Yan‐Lai Tang, et al.. (2023). Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity. Translational Pediatrics. 12(1). 31–45. 12 indexed citations
13.
Huang, Ying, Jieyi Ma, Hui Han, et al.. (2022). METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation. Biomarker Research. 10(1). 68–68. 21 indexed citations
14.
Tang, Wenyan, Yanhua Zhang, Yao Liao, et al.. (2021). Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice. Immunology Letters. 231. 49–60. 6 indexed citations
15.
Chen, Ken, Jialing Wu, Rui Peng, et al.. (2021). Identification of Novel Single-Nucleotide Variants With Potential of Mediating Malfunction of MicroRNA in Congenital Heart Disease. Frontiers in Cardiovascular Medicine. 8. 739598–739598. 3 indexed citations
16.
Pei, Yuxin, Lina Wang, Cong Liang, et al.. (2020). MTHFR-C677T Gene Polymorphism and Susceptibility to Acute Lymphoblastic Leukemia in Children: A Meta-Analysis. Critical Reviews in Eukaryotic Gene Expression. 30(2). 125–136. 10 indexed citations
17.
Liu, Yufeng, Michela Perego, Qiang Xiao, et al.. (2019). Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice. Journal of Clinical Investigation. 129(10). 4261–4275. 62 indexed citations
18.
Qin, Ge, Yizhuo Li, Xiangdong Xu, et al.. (2019). Panobinostat (LBH589) inhibits Wnt/β-catenin signaling pathway via upregulating APCL expression in breast cancer. Cellular Signalling. 59. 62–75. 28 indexed citations
19.
Wu, Zhenyu, Lifu Wang, Yan‐Lai Tang, & Xi Sun. (2017). Parasite-Derived Proteins for the Treatment of Allergies and Autoimmune Diseases. Frontiers in Microbiology. 8. 2164–2164. 56 indexed citations
20.
Tang, Yan‐Lai, et al.. (2015). Flavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms. Leukemia & lymphoma. 56(8). 2398–2407. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026